Journey Medical Corp (DERM) — Capital Reinvestment Ratio
Journey Medical Corp (DERM) has a Capital Reinvestment Ratio of 22.62x as of March 2022, meaning it reinvests 23% of its operating cash flow ($884.00K) in capital expenditures ($20.00 Million). Check tangible equity quality of Journey Medical Corp to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Journey Medical Corp Capital Reinvestment Ratio (2019–2023)
This chart tracks Journey Medical Corp's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see DERM cash flow conversion.
Annual Capital Reinvestment Ratio for Journey Medical Corp (2019–2023)
Year-by-year Capital Reinvestment Ratio for Journey Medical Corp from 2019 to 2023. See Journey Medical Corp free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.95x | $5.24 Million | $5.00 Million | ▲ +308.1% |
| 2020 | 0.23x | $5.13 Million | $1.20 Million | ▼ -12.1% |
| 2019 | 0.27x | $9.02 Million | $2.40 Million | — |